Immunome (IMNM) traded down -1.48 % during a 24 hours period ending at 05:43 AM Central Europe on Tuesday 27th. One Immunome stock can currently be bought for about USD 17.89 on popular exchanges. Current supply of Immunome stocks is 113.4 mn. Immunome has a current market capitalization of USD 2 bn and approximately USD 24.8 mn worth of Immunome was traded on exchanges in the last 24 hours. Since last month end, Immunome has traded -19.47 % down. Simple moving average of last 200 days is at USD 22.55. The highest price of past 52 weeks was recorded at USD 30.06 on 08/19/2026. 52 weeks low was at USD 14.64 on 11/07/2025.
Here is how related stocks have performed in the past 24 hours:
Transmedics (TMDX) traded down -1.83 % and now trades at USD 70.63. Transmedics has a market capitalisation of USD 2.4 bn. Current price/earnings ratio for Transmedics is 17.87.
Clover Health Investments (CLOV) traded down -2.75 % and now trades at USD 4.56. Current market capitalisation for Clover Health Investments is USD 2.4 bn.
Hyperliquid Strategies (PURR) traded up 1.15 % and now trades at USD 9.07. Current market capitalisation for Hyperliquid Strategies is USD 2.4 bn. Hyperliquid Strategies has a current price to earnings ratio of 3.62.
Beam Therapeutics (BEAM) traded down -2.08 % and now trades at USD 23.79. Current market capitalisation for Beam Therapeutics is USD 2.4 bn.
Brookdale Senior Living (BKD) traded down -1.08 % and now trades at USD 9.76. Brookdale Senior Living has a market capitalisation of USD 2.4 bn.
About Immunome
Immunome, Inc. is a biotechnology company based in Exton, Pennsylvania, United States. The company specializes in developing and commercializing novel therapeutic antibodies and medicines for treating various diseases. Immunome serves patients residing in the state of Pennsylvania. You can find more information about the company and its activities on their website, which is www.immunome.com . The company’s stock is traded on the Nasdaq stock exchange.